New hope for stroke patients: drug trial aims to stop secondary brain injury
NCT ID NCT05664191
Summary
This study is testing whether a drug called levosimendan can prevent dangerous complications after a severe brain bleed caused by a ruptured aneurysm. The trial will involve 30 adult patients in intensive care, who will receive either the drug or a placebo. The main goal is to see if the treatment reduces brain vessel spasms and delayed brain injury within two weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUB-ARACHNOID HAEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Lariboisière, Service d'anesthésie Réanimation
RECRUITINGParis, France, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.